Estimated Asian adult soy protein and isoflavone intakes

Nutrition and Cancer

Volumn 55, Issue 1, 2006, Pages 1-12

  Messina, Mark ^a,b   Nagata, Chisato ^c   Wu, Anna H ^d  

^a LOMA LINDA UNIVERSITY   (United States)

^b Nutrition Matters Inc   (United States)

^c GIFU UNIVERSITY   (Japan)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE DERIVATIVE; SOYBEAN PROTEIN;

ASIAN; BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CHINA; DIETARY INTAKE; FOOD INTAKE; HONG KONG; HUMAN; INDONESIA; JAPAN; NORTH KOREA; PROSTATE CANCER; PROTEIN INTAKE; REVIEW; SINGAPORE; SOYBEAN; THAILAND;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTICARCINOGENIC AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; DIET SURVEYS; FEMALE; HONG KONG; HUMANS; INFANT; ISOFLAVONES; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; SINGAPORE; SOYBEAN PROTEINS;

GLYCINE MAX;

EID: 33749160353     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5501_1     Document Type: Review

References (117)

1. Messina M and Barnes S: The role of soy products in reducing risk of cancer. JNCI 83, 541-546, 1991.
2. Pisani P, Parkin DM, Bray F, and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83, 18-29, 1999.
3. Ajiki W, Tsukuma H, and Oshima A: Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34, 352-356, 2004.
4. Adlercreutz H: Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 83, 113-118, 2002.
5. Messina M: Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 61, 117-131, 2003.
6. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, et al.: Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146, 294-306, 1997.
7. Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, et al.: Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. Br Med J 328, 1285-1290, 2004.
8. Spector D, Anthony M, Alexander D, and Arab L: Soy consumption and colorectal cancer. Nutr Cancer 47, 1-12, 2003.
9. Guo JY, Li X, Browning JD Jr, Rottinghaus GE, Lubahn DB, et al.: Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. J Nutr 134, 179-182, 2004.
10. Sarkar FH and Li Y: Soy isoflavones and cancer prevention. Cancer Invest 21, 744-757, 2003.
11. Messina M and Flickinger B: Hypothesized anticancer effects of soy: evidence points toward isoflavones as the primary anticarcinogens. Pharm Biol 40, S6-S23, 2002.
12. Nestel P: Isoflavones: their effects on cardiovascular risk and functions. Curr Opin Lipidol 14, 3-8, 2003.
13. Messina M, Ho S, and Alekel DL: Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Curr Opin Clin Nutr Metab Care 7, 649-658, 2004.
14. Messina M and Hughes C: Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. J Med Food 6, 1-11, 2003.
15. Golbitz P: Soyfoods: The U.S. Market 2002. Bar Harbor, ME: Soyatech, 2002.
16. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, et al.: Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131, S1362-S1375, 2001.
17. Nurmi T, Mazur W, Heinonen S, Kokkonen J, and Adlercreutz H: Isoflavone content of the soy based supplements. J Pharm Biomed Anal 28, 1-11, 2002.
18. Howes JB and Howes LG: Content of isoflavone-containing preparations. Med J Aust 176, 135-136, 2002.
19. Munro IC, Harwood M, Hlywka JJ, Stephen AM, Doull J, et al.: Soy isoflavones: a safety review. Nutr Rev 61, 1-33, 2003.
20. Siegel-Itzkovich J: Health committee warns of potential dangers of soya. Br Med J 331, 254, 2005.
21. Comité de Nutrition de la Société Française de Pédiatrie: Phytoestrogens and soy foods in infants and children: caution is needed. Arch Pediatr 13, 235-237, 2006.
22. Allred CD, Allred KF, Ju YH, Virant SM, and Helferich WG: Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (mcf-7) tumors in a dose-dependent manner. Cancer Res 61, 5045-5050, 2001.
23. Messina MJ and Loprinzi CL: Soy for breast cancer survivors: a critical review of the literature. J Nutr 131, S3095-S3108, 2001.
24. Bouker KB and Hilakivi-Clarke L: Genistein: does it prevent or promote breast cancer? Environ Health Perspect 108, 701-708, 2000.
25. Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, et al.: Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25, 1649-1657, 2004.
26. Messina M and Messina V: Provisional recommended soy protein and isoflavone intakes for healthy adults: rationale. Nutr Today 38, 100-109, 2003.
27. U.S. Food and Drug Administration: Food labeling, health claims, soy protein, and coronary heart disease. Fed Reg 57, 699-733, 1999.
28. U.S. Department of Agriculture, Agricultural Research Service: USDA-Iowa State University Database on the Isoflavone Content of Foods, Release 1.3, 2002. Nutrient Data Laboratory Web site: http://www.nal.usda.gov/fhic/foodcomp/Data/ isoflav/isoflav.html
29. Liu Z, Li W, Sun J, Liu C, Zeng Q, et al.: Intake of soy foods and soy isoflavones by rural adult women in China. Asia Pac J Clin Nutr 13, 204-209, 2004.
30. Messina M: Isoflavone intakes by Japanese were overestimated. Am J Clin Nutr 62, 645, 1995.
31. Cassidy A, Bingham S, and Setchell KD: Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60, 333-340, 1994.
32. Nagata C: Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int J Epidemiol 29, 832-836, 2000.
33. Ho SC, Woo J, Lam S, Chen Y, Sham A, et al.: Soy protein consumption and bone mass in early postmenopausal Chinese women. Osteoporos Int 14, 835-842, 2003.
34. Ho SC, Woo JL, Leung SS, Sham AL, Lam TH, et al.: Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J Nutr 130, 2590-2593, 2000.
35. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, et al.: Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85, 372-378, 2001.
36. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, et al.: Soy product intake is inversely associated with serum homocysteine level in premenopausal Japanese women. J Nutr 133, 797-800, 2003.
37. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, et al.: Serum concentrations of estradiol and dehydroepiandrosterone sulfate and soy product intake in relation to psychologic well-being in peri- and postmenopausal Japanese women. Metabolism 49, 1561-1564, 2000.
38. Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N, et al.: Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev Med 31, 308-314, 2000.
39. Nagata C, Takatsuka N, Kurisu Y, and Shimizu H: Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 128, 209-213, 1998.
40. Nagata C, Kabuto M, Kurisu Y, and Shimizu H: Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutr Cancer 29, 228-233, 1997.
41. Horiuchi T, Onouchi T, Takahashi M, Ito H, and Orimo H: Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 11, 721-724, 2000.
42. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, et al.: Dietary effects on breast-cancer risk in Singapore. Lancet 337, 1197-2000, 1991.
43. Franke AA, Custer LJ, Wang W, and Shi CY: HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217, 263-273, 1998.
44. Murphy PA, Song T, Buseman G, Barua K, Beecher GR, et al.: Isoflavones in retail and institutional soy foods. J Agric Food Chem 47, 2697-2704, 1999.
45. Erdman JW Jr, Badger TM, Lampe JW, Setchell KD, and Messina M: Not all soy products are created equal: caution needed in interpretation of research results. J Nutr 134, S1229-S1233, 2004.
46. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, et al.: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262, 5592-5595, 1987.
47. Folman Y and Pope GS: The interaction in the immature mouse ofpotent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 34, 215-225, 1966.
48. Wietrzyk J, Grynkiewicz G, and Opolski A: Phytoestrogens in cancer prevention and therapy - mechanisms of their biological activity. Anticancer Res 25, 2357-2366, 2005.
49. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, et al.: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263, 1998.
50. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, and Leitman DC: Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276, 17808-17814, 2001.
51. Kostelac D, Rechkemmer G, and Briviba K: Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 51, 7632-7635, 2003.
52. Signoretti S and Loda M: Estrogen receptor beta in prostate cancer: brake pedal or accelerator? Am J Pathol 159, 13-16, 2001.
53. Weihua Z, Lathe R, Warner M, and Gustafsson JA: An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99, 13589-13594, 2002.
54. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, et al.: Estrogen receptor {beta} inhibits 17{beta}-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101, 1566-1571, 2004.
55. Popkin BM: The nutrition transition in low-income countries: an emerging crisis. Nutr Rev 52, 285-298, 1994.
56. Kobayashi S: Trends in national survey of Japan. Nutr Health 8, 91-96, 1992.
57. Kagawa Y: Impact of westernization on the nutrition of Japanese: changes in physique, cancer, longevity and centenarians. Prev Med 7, 205-217, 1978.
58. Fukutake M, Takahashi M, Ishida K, Kawamura H, Sugimura T, et al.: Quantification of genistein and genistin in soybeans and soybean products. Food Chem Toxicol 34, 457-461, 1996.
59. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, et al.: Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 128, 1710-1715, 1998.
60. Ohta T, Nakatsugi S, Watanabe K, Kawamori T, Ishikawa F, et al.: Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones. Carcinogenesis 21, 937-941, 2000.
61. Fukuba H: Food policy for health in Japan. Nutr Health 8, 177-190, 1992.
62. Nakamura Y, Tsuji S, and Tonogai Y: Determination of the levels of isoflavonoids in soybeans and soy-derived foods and estimation of isoflavonoids in the Japanese daily intake. J AOAC Int 83, 635-650, 2000.
63. Oiso T: Changing food patterns in Japan. In Nutrition in Health and Disease and International Development: Symposia from the XII International Congress of Nutrition. New York: Alan R. Liss, 1981.
64. Keys A and Kimura N: Diets of middle-aged farmers in Japan. Am J Clin Nutr 23, 212-223, 1970.
65. Wang M-F, Kishi K, Takahashi T, Komatsu T, Ohnaka M, et al.: Efficiency of utilization of soy protein isolate in Japanese young men. J Nutr Sci Vitaminol 29, 201-216, 1983.
66. Nagaya T: Soy and legume intake. Nagoya City, Japan, 2000.
67. Nagata C, Takatsuka N, Kawakami N, and Shimizu H: Association of diet with the onset of menopause in Japanese women. Am J Epidemiol 152, 863-867, 2000.
68. Nagata C, Takatsuka N, Kawakami N, and Shimizu H: A prospective cohort study of soy product intake and stomach cancer death. Br J Cancer 87, 31-36, 2002.
69. Takata Y, Maskarinec G, Franke A, Nagata C, and Shimizu H: A comparison of dietary habits among women in Japan and Hawaii. Public Health Nutr 7, 319-326, 2004.
70. Yuan JM, Wang QS, Ross RK, Henderson BE, and Yu MC: Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71, 1353-1358, 1995.
71. Sun CL, Yuan JM, Arakawa K, Low SH, Lee HP, et al.: Dietary soy and increased risk of bladder cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 11, 1674-1677, 2002.
72. Yang G, Shu XO, Jin F, Zhang X, Li HL, et al.: Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr 81, 1012-1017, 2005.
73. Zhang X, Shu XO, Gao YT, Yang G, Li Q, et al.: Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133, 2874-2878, 2003.
74. Somekawa Y, Chiguchi M, Ishibashi T, and Aso T: Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 97, 109-115, 2001.
75. Nagata C, Takatsuka N, Kawakami N, and Shimizu H: Soy product intake and premenopausal hysterectomy in a follow-up study of Japanese women. Eur J Clin Nutr 55, 773-777, 2001.
76. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, et al.: Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 130, 2243-2250, 2000.
77. Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, et al.: Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 33, 139-145, 1999.
78. Ishihara J, Sobue T, Yamamoto S, Sasaki S, and Tsugane S: Demographics, lifestyles, health characteristics, and dietary intake among dietary supplement users in Japan. Int J Epidemiol 32, 546-553, 2003.
79. Nagata C, Hirokawa K, Shimizu N, and Shimizu H: Soy, fat and other dietary factors in relation to premenstrual symptoms in Japanese women. BJOG 111, 594-599, 2004.
80. Mei J, Yeung SS, and Kung AW: High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86, 5217-5221, 2001.
81. Ho SC, Chan SG, Yi Q, Wong E, and Leung PC: Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 16, 1363-1369, 2001.
82. Frankenfeld CL, Lampe JW, Shannon J, Gao DL, Ray RM, et al.: Frequency of soy food consumption and serum isoflavone concentrations among Chinese women in Shanghai. Public Health Nutr 7, 765-772, 2004.
83. Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, et al.: Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 12, 665-668, 2003.
84. Zhang M, Xie X, Lee AH, and Binns CW: Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast China. Nutr Cancer 49, 125-130, 2004.
85. Saio K: Soybean food industry for the 21st century. Korean Soybean Digest 15, 94-105, 1998.
86. Simoons: Food in China. A Cultural and Historical Inquiry. Boca Raton, FL: CRC Press, 1991.
87. Tokudome S, Imaeda N, Tokudome Y, Fujiwara N, Nagaya T, et al.: Relative validity of a semi-quantitative food frequency questionnaire versus 28 day weighed diet records in Japanese female dietitians. Eur J Clin Nutr 55, 735-742, 2001.
88. Matsuzaki T: Longevity, diet, and nutrition in Japan: epidemiological studies. Nutr Rev 50, 355-359, 1992.
89. Willcox BJ, Fuchigami K, Willcox DC, Kendall CWC, Suzuki M, et al.: Isoflavone intake in Japanese and Japanese-Canadians. Am J Clin Nutr 61, 901 (abstract 58), 1995.
90. Willcox BJ, Jenkins DJA, Fuchigami K, Willcox DC, Suzuki M, et al.: Dietary westernization and chronic disease in Japan. FASEB J 1995.
91. Willcox BJ, Hensrud WW, Jenkins DJA, Fuchigami K, Willcox DC, et al.: The dietary habits of Japan's longest-lived women. Am J Clin Nutr 66, 210 (abstract 42), 1997.
92. Wakai K, Ohno Y, Genka K, Ohmine K, Kawamura T, et al.: Risk modification in lung cancer by a dietary intake of preserved foods and soyfoods: findings from a case-control study in Okinawa, Japan. Lung Cancer 25, 147-159, 1999.
93. Kanke Y, Iitoi Y, Twasaki M, Iwase Y, Iwama M, et al.: Effects of human diets of two different Japanese populations on cancer incidence in rat hepatic drug-metabolizing and antioxidant enzyme systems. Nutr Cancer 26, 63-71, 1996.
94. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, et al.: Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54, 1093-1100, 1991.
95. Kim J and Kwon C: Estimated dietary isoflavone intake of Korean population based on National Nutrition Survey. Nutr Res 21, 947-953, 2001.
96. Wang H-J and Murphy PA: Mass balance study of isoflavones during soybean processing. J Agric Food Chem 44, 2377-2383, 1996.
97. Wang H-J and Murphy PA: Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location. J Agric Food Chem 42, 1674-1677, 1994.
98. Eldridge AC and Kwolek WF: Soybean isoflavones: effects of environment and variety on composition. J Agric Food Chem 31, 394-396, 1983.
99. Tsukamoto C, Shimada S, Igita K, Kudou S, Kokubun M, et al.: Factors affecting isoflavone content in soybean seeds: changes in isoflavones, saponins, and composition of fatty acids at different temperatures during seed development. J Agric Food Chem 43, 1184-1192, 1995.
100. Carrão-Panizzi MC and Kitamura K: Isoflavone content in Brazilian soybean cultivars. Breed Sci 45, 295-300, 1995.
101. Setchell KD and Cole SJ: Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. J Agric Food Chem 51, 4146-4155, 2003.
102. Yamamoto S, Sobue T, Sasaki S, Kobayashi M, Arai Y, et al.: Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131, 2741-2747, 2001.
103. Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, et al.: Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10, 127-135, 2000.
104. Kikuchi Y, Shimamura Y, Hirokado M, Yasuda K, and Nishijma M: Daily intake of isoflavones based on the market basket method. J Food Hygenics Soc Jpn 42, 122-127, 2001.
105. Miltyk W, Craciunescu CN, Fischer L, Jeffcoat RA, Koch MA, et al.: Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer. Am J Clin Nutr 77, 875-882, 2003.
106. Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, et al.: Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 75, 126-136, 2002.
107. Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, et al.: Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 76, 1126-1137, 2002.
108. Fischer L, Mahoney C, Jeffcoat AR, Koch MA, Thomas BE, et al.: Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia. Nutr Cancer 48, 160-170, 2004.
109. Lamartiniere CA, Zhao YX, and Fritz WA: Genistein: mammary cancer chemoprevention, in vivo mechanisms of action, potential for toxicity and bioavailability in rats. J Womens Cancer 2, 11-19, 2000.
110. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, et al.: Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491-1496, 2002.
111. Shu XO, Jin F, Dai Q, Wen W, Potter JD, et al.: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10, 483-488, 2001.
112. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, et al.: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63, 963-966, 1991.
113. Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, et al.: Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 47, 111-117, 2003.
114. Dalais FS, Meliala A, Wattanapenpaiboon N, Frydenberg M, Suter DA, et al.: Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology 64, 510-515, 2004.
115. Jarred RA, Keikha M, Dowling C, McPherson SJ, Clare AM, et al.: Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev 11, 1689-1696, 2002.
116. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, and Tsugane S: Soy, isoflavones, and breast cancer risk in Japan. JNCI 95, 906-913, 2003.
117. Lee S-K, Lee M-J, Yoon S, Kwon D-J: Estimated isoflavone intake from soy products in Korean middle-aged women. J Korean Soc Food Sci Nutr 29, 948-956, 2000.